Liver Transplantation with Tregs at UCSF

(

LITTMUS_UCSF

)

ITN Protocol #:

ITN074ST

Branded Name:

LITTMUS_UCSF

ClinicalTrials.Gov ID:

NCT03654040

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase I/II Drug Withdrawal Study of Alloantigen-Specific Tregs in Liver Transplantation

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Scientist

Study Personnel:

Protocol Chair

Sandy Feng, MD PhD sandy.feng@ucsfmedctr.org

Work:

415-353-8725

Protocol Chair

Qizhi Tang qizhi.tang@ucsf.edu

Work:

415-476-1739

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Irina Gorodetskaya igorodetskaya@immunetolerance.org

Work:

415-610-5876

Protocol Chair

Juliete Francisco Da Silva, PhD jsilva@immunetolerance.org

Work:

205-960-1065

Protocol Chair

Tielin Qin

Work:

(240) 235-6139

Protocol Chair

Sindhu Chandran, MD schandran@immunetolerance.org

Work:

415-610-4284

Protocol Chair

Natasha Watson nwatson@niaid.nih.gov

Work:

301.335.8476

Protocol Chair

Theresa Scocca Theresa_Scocca@rhoworld.com

Work:

919-595-6312